Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · ROCKWELL MEDICAL, INC. (RMTI)

Rockwell Medical posts updated corporate presentation in Form 8-K filing dated August 13, 2026

Neutral Impact 1 of 5 other Written later

Rockwell Medical furnished an updated corporate presentation to investors on August 13, 2026, as Exhibit 99.1 to a Form 8-K. The filing contains no financial results, guidance, or other quantitative figures, and the company states the information is not deemed filed under Section 18 of the Exchange Act.

Key points

  • Updated corporate presentation made available on August 13, 2026, furnished as Exhibit 99.1
  • Filed under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits)
  • Filing signed by CEO Mark Strobeck; signature block is dated May 7, 2026, which differs from the August 13, 2026 filing date

The filing

CompanyROCKWELL MEDICAL, INC. (RMTI)
Form8-K, current report
Filed with the SECAug 13, 2026, 7:27 AM ET
Accession number0001628280-26-056470

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:28 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 13, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.